Cardiac Glycosides, Antianginals, and Antidysrhythmics Flashcards
normal value of ANP
20-77
more sensitive than ANP for diagnosing HF
BNP
normal range for BNP
less than 100 pg/mL
nonpharm measures to treat HF
2 g/day of salt
decrease alcohol intake
limit fluid intake
avoid smoking
lose weight
decrease sat fat
mild exercise (walking, biking)
agents used in HF
glycosides, phosphodiesterase inhibitors, vasodilators, ACE inhibitors, ARBs, diuretics, spironolactone, nesiritide, some beta blockers
cardiac glycoside
digoxin
3 effects of digitalis on the heart
positive inotropic (increase contractility)
negative chronotropic (decrease HR)
negative dromotropic (decreases conduction of heart cells)
cardiac glycosides are also used to correct what
a-fib and a-flutter
accomplished by negatove chronotropic and negative dromotropic effects
therapeutic serum lvl for dig for dysrhythmias
0.8-2.0 ng/mL
therapeutic serum lvl for dig for HF
0.5-1.0 ng/mL
symptoms of dig toxicity
anorexia, diarrhea, N/V, bradycardia, dysrhythmias, headaches, malaise, blurred vision, visual illusions (white, green, or yellow halos around objects), confusion, and delirium
older adults more at risk
antidote for dig
digoxin-immune Fab (digibind)
what increases the effect of digoxin at its myocardial cell site of action, resulting in dig toxicity
hypokalemia (low K+)
what can interact with dig
diuretic, cortisone (hypokalemia), and antacids (decrease absorption)
this drug group inhibits the enzyme PDE, which promotes a positive inotropic response and vasodilation
phosphodiesterase inhibitors
a phosphodiesterase inhibitor (admin IV no longer than 48-72 hrs)
need to be on EKG bc dysrhythmias may result
milrinone lactate (high alert)
decrease venous blood return to the heart and result in a decrease in cardiac filling, ventricular stretching (preload), and oxygen demand on the heart
vasodilators
dilate venules and arteriole, which improves renal blood flow and decreases blood fluid volume
ACE inhibitors
-pril